Clinical Trial Update: Pharmacokinetics of Levofloxacin in Intensive Care Unit [Phase 4]

View source ↗

Summary

Phase 4 study updates the pharmacokinetics of levofloxacin in ICU patients. The trial includes individuals with community-acquired pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Intensive Care Unit Syndrome, Community-acquired Pneumonia | Phase 4 | Status: COMPLETED